Skip to main content
Clinical Trials/CTRI/2020/11/029368
CTRI/2020/11/029368Not yet recruitingPhase 3

A PRECLINICAL AND COMPARATIVE CLINICAL TRIAL OF VARMAM THERAPY WITH AND WITHOUT KURUNTHOTTI KASHAYAM (INTERNALLY) IN THE MANAGEMENT OF CEGANAVATHAM (CERVICAL SPONDYLOSIS)

National Institute of Siddha1 site in 1 country40 target enrollmentStarted: November 29, 2020Last updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Enrollment
40
Locations
1
Primary Endpoint
UNIVERSAL PAIN ASSESSMENT SCALE

Study Overview

Brief Summary

This is the comparative two arm clinical study to evaluate the efficacy of varmam therapy with and without kurunthotti kashayam in the management of ceganavatham in 40 patients for 48 days. The outcome will be measured by Universal pain scale and reduction in clinical symptoms.

Study Design

Study Type
Interventional
Allocation
Computer generated randomization

Eligibility Criteria

Ages
25.00 Year(s) to 55.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • •Pain present behind the neck Region, aggravated by movement
  • •Neck stiffness
  • •Difficulty in flexion and extension of neck 4.pain radiating to shoulder blade, top of the shoulder, upper arm and back of the head
  • •Dizziness or vertigo
  • •Numbness in both upper limb
  • •Pain radiating to.

Exclusion Criteria

  • •Patient with uncontrolled hypertension 2.pregancy and lactation
  • •Cervical rib
  • •Spina bifida
  • •Ankylosis spondylosis
  • •Rheumatoid arthritis
  • •Patient with thyroid
  • •Any trauma history
  • •Loss of bowel and bladder control
  • •Dysphagia
  • •Fracture in neck region
  • •Coronary artery disease
  • •Tuberculosis
  • •Severe osteoporosis
  • •Neck surgery.

Outcomes

Primary Outcomes

UNIVERSAL PAIN ASSESSMENT SCALE

Time Frame: 48 days

Secondary Outcomes

  • To study the siddha basic principles relevant to the diseases(48 days)

Investigators

Sponsor Class
Research institution and hospital

Study Sites (1)

Loading locations...

Similar Trials